These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25910754)

  • 1. Phospho-ΔNp63α-responsive microRNAs contribute to the regulation of necroptosis in squamous cell carcinoma upon cisplatin exposure.
    Ratovitski EA
    FEBS Lett; 2015 May; 589(12):1352-8. PubMed ID: 25910754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospho-ΔNp63α/SREBF1 protein interactions: bridging cell metabolism and cisplatin chemoresistance.
    Huang Y; Bell LN; Okamura J; Kim MS; Mohney RP; Guerrero-Preston R; Ratovitski EA
    Cell Cycle; 2012 Oct; 11(20):3810-27. PubMed ID: 22951905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospho-ΔNp63α-dependent microRNAs modulate chemoresistance of squamous cell carcinoma cells to cisplatin: at the crossroads of cell life and death.
    Ratovitski EA
    FEBS Lett; 2013 Aug; 587(16):2536-41. PubMed ID: 23831023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospho-ΔNp63α regulates AQP3, ALOX12B, CASP14 and CLDN1 expression through transcription and microRNA modulation.
    Ratovitski EA
    FEBS Lett; 2013 Nov; 587(21):3581-6. PubMed ID: 24070899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure.
    Huang Y; Chuang AY; Ratovitski EA
    Cell Cycle; 2011 Nov; 10(22):3938-47. PubMed ID: 22071691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta Np63 alpha – Responsive microRNA Modulate the Expression of Metabolic Enzymes.
    Ratovitski EA
    Curr Pharm Biotechnol; 2015; 16(9):832-50. PubMed ID: 26087991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospho-ΔNp63α-dependent regulation of autophagic signaling through transcription and micro-RNA modulation.
    Huang Y; Guerrero-Preston R; Ratovitski EA
    Cell Cycle; 2012 Mar; 11(6):1247-59. PubMed ID: 22356768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
    Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
    Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospho-ΔNp63α/microRNA feedback regulation in squamous carcinoma cells upon cisplatin exposure.
    Huang Y; Kesselman D; Kizub D; Guerrero-Preston R; Ratovitski EA
    Cell Cycle; 2013 Feb; 12(4):684-97. PubMed ID: 23343772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospho-ΔNp63α/Rpn13-dependent regulation of LKB1 degradation modulates autophagy in cancer cells.
    Huang Y; Ratovitski EA
    Aging (Albany NY); 2010 Dec; 2(12):959-68. PubMed ID: 21191146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomas.
    Ratovitski EA
    Cell Cycle; 2014; 13(5):749-61. PubMed ID: 24394434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospho-DeltaNp63alpha/NF-Y protein complex transcriptionally regulates DDIT3 expression in squamous cell carcinoma cells upon cisplatin exposure.
    Huang Y; Chuang AY; Romano RA; Liégeois NJ; Sinha S; Trink B; Ratovitski E; Sidransky D
    Cell Cycle; 2010 Jan; 9(2):328-38. PubMed ID: 20023394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells.
    Huang Y; Chuang A; Hao H; Talbot C; Sen T; Trink B; Sidransky D; Ratovitski E
    Cell Death Differ; 2011 Jul; 18(7):1220-30. PubMed ID: 21274007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
    Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
    Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.
    Huang Y; Jeong JS; Okamura J; Sook-Kim M; Zhu H; Guerrero-Preston R; Ratovitski EA
    Cell Cycle; 2012 Jun; 11(12):2367-79. PubMed ID: 22672905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-203 inhibits cell proliferation and promotes cisplatin induced cell death in tongue squamous cancer.
    Lin J; Lin Y; Fan L; Kuang W; Zheng L; Wu J; Shang P; Wang Q; Tan J
    Biochem Biophys Res Commun; 2016 Apr; 473(2):382-7. PubMed ID: 26946357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of RIP3 potentiates cisplatin chemoresistance by triggering HSP90-ERK pathway mediated DNA repair in esophageal squamous cell carcinoma.
    Sun Y; Zhai L; Ma S; Zhang C; Zhao L; Li N; Xu Y; Zhang T; Guo Z; Zhang H; Xu P; Zhao X
    Cancer Lett; 2018 Apr; 418():97-108. PubMed ID: 29331417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MLKL-PITPα signaling-mediated necroptosis contributes to cisplatin-triggered cell death in lung cancer A549 cells.
    Jing L; Song F; Liu Z; Li J; Wu B; Fu Z; Jiang J; Chen Z
    Cancer Lett; 2018 Feb; 414():136-146. PubMed ID: 29104146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor interactive protein kinase 3 promotes Cisplatin-triggered necrosis in apoptosis-resistant esophageal squamous cell carcinoma cells.
    Xu Y; Lin Z; Zhao N; Zhou L; Liu F; Cichacz Z; Zhang L; Zhan Q; Zhao X
    PLoS One; 2014; 9(6):e100127. PubMed ID: 24959694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells.
    Fu X; Tian J; Zhang L; Chen Y; Hao Q
    FEBS Lett; 2012 May; 586(9):1279-86. PubMed ID: 22465665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.